Introduction of exogenous T-cell receptors into human hematopoietic progenitors results in exclusion of endogenous T-cell receptor expression

Molecular Therapy

Volumn 21, Issue 5, 2013, Pages 1055-1063

  Vatakis, Dimitrios N ^a,b   Arumugam, Balamurugan ^b   Kim, Sohn G ^a,b   Bristol, Gregory ^a,b   Yang, Otto ^b   Zack, Jerome A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; MELAN A; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CD8+ T LYMPHOCYTE; CELL SURFACE; CONFERENCE PAPER; CONTROLLED STUDY; FETUS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; STEM CELL GENE THERAPY; VIRAL GENE DELIVERY SYSTEM;

EID: 84877030619     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.28     Document Type: Conference Paper

References (28)

1. Morgan, RA, Dudley, ME, Wunderlich, JR, Hughes, MS, Yang, JC, Sherry, RM et al. (2006). Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129.
2. Miles, JJ, Silins, SL and Burrows, SR (2006). Engineered T cell receptors and their potential in molecular medicine. Curr Med Chem 13: 2725-2736.
3. Rosenberg, SA, Restifo, NP, Yang, JC, Morgan, RA and Dudley, ME (2008). Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8: 299-308.
4. Chambers, CA, Kuhns, MS, Egen, JG and Allison, JP (2001). CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 19: 565-594.
5. Klebanoff, CA, Gattinoni, L and Restifo, NP (2006). CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 211: 214-224.
6. Dudley, ME, Wunderlich, JR, Robbins, PF, Yang, JC, Hwu, P, Schwartzentruber, DJ et al. (2002). Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298: 850-854.
7. Yee, C, Thompson, JA, Roche, P, Byrd, DR, Lee, PP, Piepkorn, M et al. (2000). Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med 192: 1637-1644.
8. Bendle, GM, Linnemann, C, Hooijkaas, AI, Bies, L, de Witte, MA, Jorritsma, A et al. (2010). Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy. Nat Med 16: 565-70, 1p following 570.
9. Willemsen, RA, Weijtens, ME, Ronteltap, C, Eshhar, Z, Gratama, JW, Chames, P et al. (2000). Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther 7: 1369-1377.
10. Yang, L and Baltimore, D (2005). Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proc Natl Acad Sci USA 102: 4518-4523.
11. Yang, L, Qin, XF, Baltimore, D and Van Parijs, L (2002). Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells. Proc Natl Acad Sci USA 99: 6204-6209.
12. Payne, KJ and Crooks, GM (2007). Immune-cell lineage commitment: translation from mice to humans. Immunity 26: 674-677.
13. Melkus, MW, Estes, JD, Padgett-Thomas, A, Gatlin, J, Denton, PW, Othieno, FA et al. (2006). Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12: 1316-1322.
14. Vatakis, DN, Koya, RC, Nixon, CC, Wei, L, Kim, SG, Avancena, P et al. (2011). Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proc Natl Acad Sci USA 108: E1408-E1416.
15. Kitchen, SG, Levin, BR, Bristol, G, Rezek, V, Kim, S, Aguilera-Sandoval, C et al. (2012). In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells. PLoS Pathog 8: e1002649.
16. Brady, BL, Steinel, NC and Bassing, CH (2010). Antigen receptor allelic exclusion: an update and reappraisal. J Immunol 185: 3801-3808.
17. Douek, D (2004). Thymic output and HIV infection: on the right TREC. Immunity 21: 744-745.
18. Douek, DC, McFarland, RD, Keiser, PH, Gage, EA, Massey, JM, Haynes, BF et al. (1998). Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695.
19. Balamurugan, A, Ng, HL and Yang, OO (2010). Rapid T cell receptor delineation reveals clonal expansion limitation of the magnitude of the HIV-1-specific CD8+ T cell response. J Immunol 185: 5935-5942.
20. Sleckman, BP, Khor, B, Monroe, R and Alt, FW (1998). Assembly of productive T cell receptor delta variable region genes exhibits allelic inclusion. J Exp Med 188: 1465-1471.
21. Sarukhan, A, Garcia, C, Lanoue, A and von Boehmer, H (1998). Allelic inclusion of T cell receptor alpha genes poses an autoimmune hazard due to low-level expression of autospecific receptors. Immunity 8: 563-570.
22. Jia, J, Kondo, M and Zhuang, Y (2007). Germline transcription from T-cell receptor Vbeta gene is uncoupled from allelic exclusion. EMBO J 26: 2387-2399.
23. Steinel, NC, Brady, BL, Carpenter, AC, Yang-Iott, KS and Bassing, CH (2010). Posttranscriptional silencing of V beta DJ beta C beta genes contributes to TCR beta allelic exclusion in mammalian lymphocytes. J Immunol 185: 1055-1062.
24. Brady, BL, Oropallo, MA, Yang-Iott, KS, Serwold, T, Hochedlinger, K, Jaenisch, R et al. (2010). Position-dependent silencing of germline V beta segments on TCR beta alleles containing preassembled V beta DJ beta C beta 1 genes. J Immunol 185: 3564-3573.
25. Shimizu, S, Hong, P, Arumugam, B, Pokomo, L, Boyer, J, Koizumi, N et al. (2010). A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood 115: 1534-1544.
26. Velez, MG, Kane, M, Liu, S, Gauld, SB, Cambier, JC, Torres, RM et al. (2007). Ig allotypic inclusion does not prevent B cell development or response. J Immunol 179: 1049-1057.
27. Casellas, R, Zhang, Q, Zheng, N-Y, Mathias, MD, Smith, K and Wilson, PC (2007). Ig kappa allelic inclusion is a consequence of receptor editing. J Exp Med 204: 153-160.
28. Boucontet, L, Sepulveda, N, Carneiro, J and Pereira, P (2005). Mechanisms controlling termination of V-J recombination at the TCR gamma locus: Implications for allelic and isotypic exclusion of TCR gamma chains. J Immunol 174: 3912-3919.